Near term potential - looks good This company had lots of near term potential. Been doing DD and am very impressed with products and how this is saving lives. Trying hard to talk with Inverstor relations but he is very busy and that is a good thing. With recent upgrades to software to be released soon this should open flood gates. They have been holding back the flood gates to get software perfect and now have it.
Looking to see where this company will be in six months.
Wouldn't it be great if through testing and trials vascular testing could replace more intrusive testing like MRAs etc. Heard trials already ongoing to compare results compared to other testing and repeatabiliy.